PROCESS

摘要

PROBLEM TO BE SOLVED: To provide an individuated cancer treatment method to estimate whether a patient responds to a chemotherapeutic agent by using a marker gene set, and a kit used in the method. SOLUTION: There are provided: a set of isolated marker genes comprising at least one gene identified as having differential expression as between patients who are responders and non-responders to an erbB receptor tyrosine kinase inhibitor; the gene set comprising one or more genes selected from at least the group consisting of specific 51 genes including gene-specific oligonucleotides derived from the genes; and uses of such sets in diagnostic applications. COPYRIGHT: (C)2011,JPO&INPIT